- Investing Ideas
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
Results
17
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
17 companies
Cogent Biosciences
Market Cap: US$6.5b
A clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases.
COGT
US$37.93
7D
-10.5%
1Y
219.0%
Liquidia
Market Cap: US$6.5b
A biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
LQDA
US$74.44
7D
-17.5%
1Y
186.9%
Veracyte
Market Cap: US$3.4b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$41.25
7D
-12.6%
1Y
36.5%
Kodiak Sciences
Market Cap: US$2.5b
A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.
KOD
US$41.35
7D
-8.9%
1Y
291.2%
Taysha Gene Therapies
Market Cap: US$2.0b
A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central nervous system.
TSHA
US$5.95
7D
-9.3%
1Y
102.4%
Bicara Therapeutics
Market Cap: US$1.6b
A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
BCAX
US$24.28
7D
-13.5%
1Y
108.6%
Maravai LifeSciences Holdings
Market Cap: US$1.5b
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$5.70
7D
-8.5%
1Y
118.4%
Olema Pharmaceuticals
Market Cap: US$919.6m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.
OLMA
US$10.63
7D
-11.8%
1Y
92.9%
X4 Pharmaceuticals
Market Cap: US$418.4m
A biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.
XFOR
US$4.22
7D
-9.1%
1Y
48.1%
vTv Therapeutics
Market Cap: US$383.3m
A late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases.
VTVT
US$30.12
7D
-14.8%
1Y
95.1%
Sutro Biopharma
Market Cap: US$353.3m
Operates as an oncology company.
STRO
US$20.48
7D
-19.3%
1Y
133.3%
Zentalis Pharmaceuticals
Market Cap: US$297.4m
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.
ZNTL
US$3.56
7D
-15.6%
1Y
123.9%
Adagene
Market Cap: US$245.8m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.
ADAG
US$3.70
7D
-10.0%
1Y
118.9%
Protalix BioTherapeutics
Market Cap: US$190.1m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.22
7D
-9.8%
1Y
50.0%
ImmuCell
Market Cap: US$98.6m
An animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally.
ICCC
US$10.05
7D
-8.6%
1Y
64.7%
Talphera
Market Cap: US$62.8m
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
TLPH
US$1.23
7D
-14.0%
1Y
189.2%
CapForce
Market Cap: US$49.5m
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
CFOR
US$3.75
7D
-16.7%
1Y
3,749,900.0%